Establishment Labs Holdings Inc
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgeries. The company offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides breast tissue expanders. The company sells products to physicians, hospitals, and clinics through distributors and its direct sales force… Read more
Establishment Labs Holdings Inc (ESTA) - Total Assets
Latest total assets as of September 2025: $338.89 Million USD
Based on the latest financial reports, Establishment Labs Holdings Inc (ESTA) holds total assets worth $338.89 Million USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Establishment Labs Holdings Inc - Total Assets Trend (2016–2024)
This chart illustrates how Establishment Labs Holdings Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Establishment Labs Holdings Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
Establishment Labs Holdings Inc's total assets of $338.89 Million consist of 70.1% current assets and 29.9% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 26.1% |
| Accounts Receivable | $65.00 Million | 18.7% |
| Inventory | $78.77 Million | 22.7% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $11.68 Million | 3.4% |
| Goodwill | $1.21 Million | 0.4% |
Asset Composition Trend (2016–2024)
This chart illustrates how Establishment Labs Holdings Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Establishment Labs Holdings Inc's current assets represent 70.1% of total assets in 2024, an increase from 42.4% in 2016.
- Cash Position: Cash and equivalents constituted 26.1% of total assets in 2024, up from 1.6% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 3.0% of total assets, a decrease from 7.0% in 2016.
- Asset Diversification: The largest asset category is inventory at 22.7% of total assets.
Establishment Labs Holdings Inc Competitors by Total Assets
Key competitors of Establishment Labs Holdings Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
Establishment Labs Holdings Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Establishment Labs Holdings Inc generates 0.48x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Establishment Labs Holdings Inc is currently not profitable relative to its asset base.
Establishment Labs Holdings Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.33 | 3.62 | 5.11 |
| Quick Ratio | 2.10 | 2.29 | 4.21 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $167.62 Million | $ 132.46 Million | $ 106.40 Million |
Establishment Labs Holdings Inc - Advanced Valuation Insights
This section examines the relationship between Establishment Labs Holdings Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 122.16 |
| Latest Market Cap to Assets Ratio | 3.17 |
| Asset Growth Rate (YoY) | 29.1% |
| Total Assets | $346.83 Million |
| Market Capitalization | $1.10 Billion USD |
Valuation Analysis
Premium Asset Valuation: The market values Establishment Labs Holdings Inc's assets at a significant premium ( 3.17x), suggesting investors see substantial growth potential or unique competitive advantages.
Rapid Asset Growth: Establishment Labs Holdings Inc's assets grew by 29.1% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Establishment Labs Holdings Inc (2016–2024)
The table below shows the annual total assets of Establishment Labs Holdings Inc from 2016 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $346.83 Million | +29.11% |
| 2023-12-31 | $268.64 Million | +27.28% |
| 2022-12-31 | $211.06 Million | +51.27% |
| 2021-12-31 | $139.53 Million | -10.78% |
| 2020-12-31 | $156.39 Million | +34.20% |
| 2019-12-31 | $116.53 Million | -0.04% |
| 2018-12-31 | $116.57 Million | +104.17% |
| 2017-12-31 | $57.09 Million | +93.14% |
| 2016-12-31 | $29.56 Million | -- |